Bollag G - Search Results

1

KRAS Engages AGO2 to Enhance Cellular Transformation.

Shankar S, Pitchiaya S, Malik R, Kothari V, Hosono Y, Yocum AK, Gundlapalli H, White Y, Firestone A, Cao X, Dhanasekaran SM, Stuckey JA, Bollag G, Shannon K, Walter NG, Kumar-Sinha C, Chinnaiyan AM. Shankar S, et al. Among authors: bollag g. Cell Rep. 2016 Feb 16;14(6):1448-1461. doi: 10.1016/j.celrep.2016.01.034. Epub 2016 Feb 4. Cell Rep. 2016. PMID: 26854235 Free PMC article.

2

KRAS insertion mutations are oncogenic and exhibit distinct functional properties.

White Y, Bagchi A, Van Ziffle J, Inguva A, Bollag G, Zhang C, Carias H, Dickens D, Loh M, Shannon K, Firestone AJ. White Y, et al. Among authors: bollag g. Nat Commun. 2016 Feb 8;7:10647. doi: 10.1038/ncomms10647. Nat Commun. 2016. PMID: 26854029 Free PMC article.

3

Hyperactive Ras as a therapeutic target in neurofibromatosis type 1.

Weiss B, Bollag G, Shannon K. Weiss B, et al. Among authors: bollag g. Am J Med Genet. 1999 Mar 26;89(1):14-22. Am J Med Genet. 1999. PMID: 10469432 Review.

4

Hyperactive Ras in developmental disorders and cancer.

Schubbert S, Shannon K, Bollag G. Schubbert S, et al. Among authors: bollag g. Nat Rev Cancer. 2007 Apr;7(4):295-308. doi: 10.1038/nrc2109. Nat Rev Cancer. 2007. PMID: 17384584 Review.

5

Deregulated Ras signaling in developmental disorders: new tricks for an old dog.

Schubbert S, Bollag G, Shannon K. Schubbert S, et al. Among authors: bollag g. Curr Opin Genet Dev. 2007 Feb;17(1):15-22. doi: 10.1016/j.gde.2006.12.004. Curr Opin Genet Dev. 2007. PMID: 17208427 Review.

6

Defective K-Ras oncoproteins overcome impaired effector activation to initiate leukemia in vivo.

Shieh A, Ward AF, Donlan KL, Harding-Theobald ER, Xu J, Mullighan CG, Zhang C, Chen SC, Su X, Downing JR, Bollag GE, Shannon KM. Shieh A, et al. Among authors: bollag ge. Blood. 2013 Jun 13;121(24):4884-93. doi: 10.1182/blood-2012-05-432252. Epub 2013 May 1. Blood. 2013. PMID: 23637129 Free PMC article.

7

GTPase activating proteins: critical regulators of intracellular signaling.

Donovan S, Shannon KM, Bollag G. Donovan S, et al. Among authors: bollag g. Biochim Biophys Acta. 2002 Mar 14;1602(1):23-45. doi: 10.1016/s0304-419x(01)00041-5. Biochim Biophys Acta. 2002. PMID: 11960693 Review. No abstract available.

8

PLC-γ and PI3K link cytokines to ERK activation in hematopoietic cells with normal and oncogenic Kras.

Diaz-Flores E, Goldschmidt H, Depeille P, Ng V, Akutagawa J, Krisman K, Crone M, Burgess MR, Williams O, Houseman B, Shokat K, Sampath D, Bollag G, Roose JP, Braun BS, Shannon K. Diaz-Flores E, et al. Among authors: bollag g. Sci Signal. 2013 Dec 3;6(304):ra105. doi: 10.1126/scisignal.2004125. Sci Signal. 2013. PMID: 24300897 Free PMC article.

9

Biochemical and functional characterization of germ line KRAS mutations.

Schubbert S, Bollag G, Lyubynska N, Nguyen H, Kratz CP, Zenker M, Niemeyer CM, Molven A, Shannon K. Schubbert S, et al. Among authors: bollag g. Mol Cell Biol. 2007 Nov;27(22):7765-70. doi: 10.1128/MCB.00965-07. Epub 2007 Sep 17. Mol Cell Biol. 2007. PMID: 17875937 Free PMC article.

10

Germline mutations in components of the Ras signaling pathway in Noonan syndrome and related disorders.

Kratz CP, Schubbert S, Bollag G, Niemeyer CM, Shannon KM, Zenker M. Kratz CP, et al. Among authors: bollag g. Cell Cycle. 2006 Aug;5(15):1607-11. doi: 10.4161/cc.5.15.3128. Epub 2006 Aug 1. Cell Cycle. 2006. PMID: 16921267

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters